About This Study
The purpose of this study is to learn if an inhaled study drug called LTI-03 is safe and may help people with idiopathic pulmonary fibrosis (IPF). Researchers will also look at how LTI-03 affects lung function and lung scarring. This study is for volunteers who have been diagnosed with idiopathic pulmonary fibrosis (IPF) within the past 5 years and not currently smoking.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 40 - 100+ years old
- Female
- Male
Language
- This study enrolls English speakers only
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Winston-Salem, NC